SuperworthAcumen Pharmaceuticals market cap ABOS
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $143.2M
- Highest close in our data
- $413.2M
- Aug 2023
Acumen Pharmaceuticals is worth $143.2M at the close on Oct 23, 2026, at $1.98 a share.
That is up 7% over the last year and down 64% over five years.
Its highest close in our data was $413.2M in Aug 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $143.2M | $109.6M | $230M | +12% |
| 2025 | $127.8M | $54.6M | $133.9M | +20% |
| 2024 | $106.9M | $106.9M | $268.7M | −52% |
| 2023 | $222.4M | $110M | $413.2M | +1% |
| 2022 | $221M | $133.7M | $406.2M | −19% |
| 2021 | $273.6M | $273.6M | $399M | n/a |
Against its peers
Companies in Healthcare nearest Acumen Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ABOSAcumen Pharmaceuticals | $143.2M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $202.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Acumen Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.